<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00565708</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000577892</org_study_id>
    <secondary_id>SINGAPORE-ICR-02</secondary_id>
    <secondary_id>SINGAPORE-ASCOLT</secondary_id>
    <nct_id>NCT00565708</nct_id>
  </id_info>
  <brief_title>Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers</brief_title>
  <acronym>ASCOLT</acronym>
  <official_title>Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - An International, Multi-Center, Double Blind, Randomized Placebo Controlled Phase III Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Centre, Singapore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Australasian Gastro-Intestinal Trials Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>INDOX Cancer Research Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Cancer Centre, Singapore</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We hypothesize through this randomized, placebo-controlled adjuvant study, that Aspirin in
      patients with dukes C or high risk dukes B colorectal cancer (ASCOLT) can improve survival in
      this patient population over placebo control. If indeed found to be beneficial, because
      aspirin is cheap and easy to administer, it will positively impact the lives of many
      individuals in Asia and globally.

      STUDY OBJECTIVE

      To assess the effectiveness of Aspirin against placebo control in patients with dukes C or
      high risk dukes B colorectal cancer in terms of Disease Free Survival (DFS) and Overall
      Survival (OS)

      Primary endpoints

        -  DFS among all eligible subjects (high risk Dukes B colon cancer, Dukes C colon cancer
           and rectal cancer patient sub-groups);

        -  DFS among patients with colon cancer (high-risk Dukes B and Dukes C colon cancer).

      Secondary endpoints

        -  Overall survival (OS) over 5 years

        -  DFS and OS in

             -  Chinese, Malay, Indian and other ethnic groups

             -  Resected high risk Dukes B colon cancer, Dukes C colon cancer and rectal cancer
                sub-groups, individually

             -  Compliant versus non-compliant subjects

             -  PIK3CA mutated tumors (where samples are available)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aspirin in patients with dukes C or high risk dukes B colorectal cancer can improve survival
      in this patient population over placebo control.

      Eligible patients will be randomized to treatment arms, using the following stratification
      factors:

        -  Study Centre

        -  Tumour Type

        -  Type of adjuvant chemotherapy received(exposed/not exposed to oxaliplatin

      Patients will be randomized over a 5 years' time period. After randomization, patient will
      have 3 monthly assessments with treatment for 3 years followed by 6 monthly assessments for
      additional 2 years follow-up
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Anticipated">June 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease-free survival</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>acetylsalicylic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>200mg OD for 3 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>200mg OD for 3 years</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Placebo Comparator</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetylsalicylic acid</intervention_name>
    <description>Adjuvant Therapy</description>
    <arm_group_label>acetylsalicylic acid</arm_group_label>
    <other_name>Aspirin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Male or female outpatient of ≥ 18 years of age or ≥ country's legal age for adult
             consent

          -  Dukes C colon cancer, high risk Dukes B colon cancer, Dukes B rectal cancer or Dukes C
             rectal cancer (see Appendix 1 for definition of High Risk Dukes B)

          -  Undergone complete resection of primary tumour

          -  Completed standard therapy ( at least 3 months of chemotherapy ± radiotherapy )

          -  Within 120 days of completion of standard therapy (surgery, chemotherapy ±
             radiotherapy)

          -  ECOG performance status 0 to 2

          -  Satisfactory haematological or biochemical functions (tests should be carried out
             within 8 weeks prior to randomisation): Results of clinical investigations carried out
             within 8 weeks prior to randomisation can be used in place of the required screening
             investigations. Patients with mild laboratory abnormalities can be included at the
             discretion by the site principal investigator, and after approval by ASCOLT Trial
             Management Group

          -  ANC ≥ 1.0 x 109/L

          -  Platelets ≥ 100 x 109/L

          -  Creatinine clearance ≥ 30 mL/min

          -  Total bilirubin ≤ 2.0 x the upper limit normal

          -  AST &amp; ALT ≤ 5 x the upper limit normal

          -  Completed the following investigations

          -  Colonoscopy(or CT colonogram(within 16 months prior to randomization)

          -  Imaging of abdomen (CT or CT colonogram or MRI or PET or Ultrasound) within 16 months
             prior to randomization

          -  Written informed consent

        Exclusion Criteria

          -  Pre-existing Familial adenomatous polyposis, inflammatory bowel disease or ulcerative
             colitis

          -  Active gastritis or active peptic ulcer

          -  History of continuous daily use of PPI more than 1 year prior to consent

          -  Gastrointestinal bleeding within the past one year

          -  Haemorrhagic diathesis (i.e. haemophilia)

          -  Uncontrolled hypertension (untreated systolic blood pressure &gt; 160 mmHg, or diastolic
             blood pressure &gt; 95 mmHg)

          -  History of recent cancers (except for colorectal cancers, non-melanoma skin cancers,
             basal cell carcinomas, squamous cell carcinomas) in the past 5 years

          -  History of stroke, coronary arterial disease, angina, or vascular disease

          -  Patients who are on current long term treatment (≥ 4 consecutive weeks) with Aspirin,
             NSAID or Cox-2 inhibitors

          -  History of erosive GERD or active erosive GERD on gastroscopy.

          -  Patient on active current treatment of antiplatelet agents (i.e. off-study Aspirin,
             clopidogrel, ticlopidine)

          -  Patient receiving active treatment of anticoagulants (i.e. warfarin, low molecular
             weight heparins)

          -  Pregnant, lactating, or not using adequate contraception

          -  Patient having known allergy to NSAID or Aspirin

          -  Unexplained rise of CEA (i.e. smoker with elevated CEA will not be excluded)

          -  Patient on other investigational drug

          -  Patients with HNPCC (Lynch Syndrome)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Chia, MBBS, MRCP</last_name>
    <role>Study Chair</role>
    <affiliation>National Cancer Centre, Singapore</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raghib Ali, MBBS, MRCP</last_name>
    <role>Study Chair</role>
    <affiliation>University of Oxford</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Han Chong Toh, MD, MBBS, MRCP</last_name>
    <role>Study Chair</role>
    <affiliation>National Cancer Centre, Singapore</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eva Segelov, MBBS,FRACP,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>St. Vincent's Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>John Chia, MBBS, MRCP</last_name>
    <phone>65-96536990</phone>
    <email>nmocwk@nccs.com.sg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Estelle Foo, BN,CRP</last_name>
    <email>estelle.foo.m.j@nccs.com.sg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bankstown-Lidcombe Hospital Bankstown Cancer Centre</name>
      <address>
        <city>Bankstown</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ray Asghari</last_name>
      <email>Ray.Asghari@sswahs.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Ray Asghari</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Macarthur Cancer Therapy Centre</name>
      <address>
        <city>Campbelltown</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorraine Chantrill</last_name>
      <email>Lorraine.chantrill@sswahs.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Lorraine Chantrill</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chris O'Brien Lifehouse, Clinical Research Centre</name>
      <address>
        <city>Camperdown</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Horvath</last_name>
      <email>lisa.horvath@lh.org.au</email>
    </contact>
    <investigator>
      <last_name>Lisa Horvath</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Coffs Harbour Health Campus North Coast Cancer Institute</name>
      <address>
        <city>Coffs Harbour</city>
        <state>New South Wales</state>
        <zip>2450</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Briscoe</last_name>
      <email>Kare.briscoe@ncahs.health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Karen Briscoe</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central Coast Cancer Centre Gosford Hospital</name>
      <address>
        <city>Gosford</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Wong</last_name>
      <email>Matt.wong@health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Matthew Wong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Newcastle private Hospital</name>
      <address>
        <city>New Lambton Heights</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anontino Bonaventura</last_name>
      <email>Tony.Bonaventura@calvarymater.org.au</email>
    </contact>
    <investigator>
      <last_name>Anontino Bonaventura</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orange Health Service</name>
      <address>
        <city>Orange</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Zielinski</last_name>
      <email>Robert.zielinski@health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Robert Zielinski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Port Macquarie Base Hospital North Coast Cancer Institute</name>
      <address>
        <city>Port Macquarie</city>
        <state>New South Wales</state>
        <zip>2444</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Begbie</last_name>
      <email>Stephen.Begbie@ncahs.health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Stephen Begbie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northern Cancer Institute, St Leonards</name>
      <address>
        <city>St Leonards</city>
        <state>New South Wales</state>
        <zip>2065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nick Pavlakis</last_name>
      <email>nick.pavlakis@sydney.edu.au</email>
    </contact>
    <investigator>
      <last_name>Nick Pavlakis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwest Cancer Centre Tamworth Hospital</name>
      <address>
        <city>Tamworth</city>
        <state>New South Wales</state>
        <zip>2340</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathew George</last_name>
      <email>Mathew.george@hnehealth.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Mathew George</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Tweed Hospital</name>
      <address>
        <city>Tweed Heads</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ehtesham Abdi</last_name>
      <email>Ehtesham.Abdi@ncahs.health.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>Ehtesham Abdi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Calvary Mater Newcastle Hospital</name>
      <address>
        <city>Waratah</city>
        <state>New South Wales</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Lynam</last_name>
      <email>james.lynam@calvarymater.org.au</email>
    </contact>
    <investigator>
      <last_name>James Lynam</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Darwin Hospital</name>
      <address>
        <city>Tiwi</city>
        <state>Northern Territory</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Narayan Karanth</last_name>
      <email>Narayan.Karanth@nt.gov.au</email>
    </contact>
    <investigator>
      <last_name>Narayan Karanth</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Townsville Hospital</name>
      <address>
        <city>Douglas</city>
        <state>Queensland</state>
        <zip>4814</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suresh Varma</last_name>
      <email>Suresh.varma@health.qld.gov.au</email>
    </contact>
    <investigator>
      <last_name>Suresh Varma</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Brisbane and Women's Hospital</name>
      <address>
        <city>Herston</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Eastgate</last_name>
      <email>Melissa.eastgate@health.qld.gov.au</email>
    </contact>
    <investigator>
      <last_name>Melissa Eastgate</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lyell McEwin Hospital</name>
      <address>
        <city>Elizabeth Vale</city>
        <state>South Australia</state>
        <zip>5112</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Timothy Price</last_name>
      <email>Timothy.Price@health.sa.gov.au</email>
    </contact>
    <investigator>
      <last_name>Timothy Price</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Hobart Hospital</name>
      <address>
        <city>Hobart</city>
        <state>Tasmania</state>
        <zip>7000</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louise Nott</last_name>
      <email>Lnott@shhs.tas.gov.au</email>
    </contact>
    <investigator>
      <last_name>Louise Nott</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Border Medical Oncology Research Unit</name>
      <address>
        <city>Albury</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Craig Underhill</last_name>
      <email>Craig.underhill@bordermedonc.com.au</email>
    </contact>
    <investigator>
      <last_name>Craig Underhill</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ballarat Regional Integrated Cancer Centre</name>
      <address>
        <city>Ballarat</city>
        <state>Victoria</state>
        <zip>3350</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geoffrey Chong</last_name>
      <email>Geoffreyc@bhs.org.au</email>
    </contact>
    <investigator>
      <last_name>Geoffrey Chong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barwon Health Andrew Love Cancer Centre</name>
      <address>
        <city>Geelong</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mustafa Khasraw</last_name>
      <email>m.khasraw@barwonhealth.org.au</email>
    </contact>
    <investigator>
      <last_name>Mustafa Khasraw</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Health Cancer Clinical Trials</name>
      <address>
        <city>Heidelberg</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Niall Tebbutt</last_name>
      <email>Niall.tebbutt@ludwig.edu.au</email>
    </contact>
    <investigator>
      <last_name>Niall Tebbutt</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Monash Health Medical Oncology</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3165</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Strickland</last_name>
      <email>ahstrickland@tpg.com.au</email>
    </contact>
    <investigator>
      <last_name>Andrew Strickland</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Goulburn Valley Health</name>
      <address>
        <city>Shepparton</city>
        <state>Victoria</state>
        <zip>3630</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ZeeWan Wong</last_name>
      <email>Zeewan.wong@gvhealth.org.au</email>
    </contact>
    <investigator>
      <last_name>ZeeWan Wong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St John of God Healthcare Southwest Oncology</name>
      <address>
        <city>Warrnambool</city>
        <state>Victoria</state>
        <zip>3280</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Theresa Hayes</last_name>
      <email>thayes@swarh.vic.gov.au</email>
    </contact>
    <investigator>
      <last_name>Theresa Hayes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sir Charles Gairdner Hospital</name>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guy van Hazel</last_name>
      <email>Guy.VanHazel@health.wa.gov.au</email>
    </contact>
    <investigator>
      <last_name>Guy van Hazel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St John of God Hospital Subiaco</name>
      <address>
        <city>Subiaco</city>
        <state>Western Australia</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tom Van Hagen</last_name>
    </contact>
    <investigator>
      <last_name>Tom Van Hagen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing University Cancer Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xi Cheng Wang</last_name>
      <email>xicheng.wang@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Shen Lin</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xi Chen Wang</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Foshan City</name>
      <address>
        <city>Foshan</city>
        <state>Guangdong</state>
        <zip>528000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Wang</last_name>
      <email>wangwei@fsyyy.com</email>
    </contact>
    <investigator>
      <last_name>Wei Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fen Feng</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sixth Affiliated Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510655</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yan Hong Deng</last_name>
      <email>littleqicat@163.com</email>
    </contact>
    <investigator>
      <last_name>Jian Ping Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jian Xiao</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yan Hong Deng</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guangdong General Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>De Qing Wu</last_name>
      <email>wdq233@139.com</email>
    </contact>
    <investigator>
      <last_name>Yong Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>De Qing Wu</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sun Yat Sen University Cancer Center</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gong Chen</last_name>
      <email>chengong@sysucc.org.cn</email>
    </contact>
    <investigator>
      <last_name>Gong Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongshan City People's Hospital</name>
      <address>
        <city>Zhongshan</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiao Mei Jiang</last_name>
      <email>Jiangxiaomei_007@163.com</email>
    </contact>
    <investigator>
      <last_name>Jie-Wen Peng</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiao Mei Jiang</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jinan Central Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu Ping Sun</last_name>
      <email>sunyuping@live.cn</email>
    </contact>
    <investigator>
      <last_name>Yu Ping Sun</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yantai Yuhuangding Hospital</name>
      <address>
        <city>Yantai</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liang Ming Zhang</last_name>
      <email>zhanglmdr@163.com</email>
    </contact>
    <investigator>
      <last_name>Liang Ming Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong Xu</last_name>
      <email>xudongzju@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Dong Xu</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>KeFeng Ding</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital - Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Yau</last_name>
    </contact>
    <investigator>
      <last_name>Thomas Yau</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wai Lun Law</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Nantong University</name>
      <address>
        <city>Nantong</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guo Xin Mao</last_name>
      <email>maogx33@163.com</email>
    </contact>
    <investigator>
      <last_name>Guo Xin Mao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kidwai Memorial Institute of Oncology</name>
      <address>
        <city>Bangalore</city>
        <zip>560029</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Loknatha Dasappa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Amrita Institute of Medical Sciences</name>
      <address>
        <city>Cochin</city>
        <country>India</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>G. Kuppuswamy Naidu Memorial Hospital</name>
      <address>
        <city>Coimbatore</city>
        <zip>641 037</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sivanesan</last_name>
      <email>sivanesan@jipmer.net</email>
    </contact>
    <investigator>
      <last_name>Sivanesan B</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nizam's Institute of Medical Sciences</name>
      <address>
        <city>Hyderabad</city>
        <zip>500 082</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>G Sadashivudu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tata Memorial Hospital</name>
      <address>
        <city>Mumbai</city>
        <zip>400012</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Shaesta Mehta</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>All India Institute of Medical Sciences</name>
      <address>
        <city>New Delhi</city>
        <zip>110029</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Atul Sharma</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regional Cancer Center</name>
      <address>
        <city>Trivandrum</city>
        <zip>695011</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sajeed</last_name>
      <email>drsajeed.rcc@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Sajeed A</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christian Medical College and Hospital</name>
      <address>
        <city>Vellore</city>
        <zip>632002</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raju Chacko</last_name>
    </contact>
    <investigator>
      <last_name>Raju T Chacko</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dharmais Cancer Hospital</name>
      <address>
        <city>Jakarta</city>
        <zip>11420</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ajodei Soemardi</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Syafrizal Syafei</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cipto Mangunkusumo General Hospital</name>
      <address>
        <city>Jakarta</city>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Rumah Sakit RSUP Dr. Sardjito</name>
      <address>
        <city>Yogyakarta</city>
        <zip>55284</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Johan Kurnianda</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hallym University Sacred Heart Hospital</name>
      <address>
        <city>Anyang-si</city>
        <state>Gyeonggi-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dae Young Zang</last_name>
      <email>fhdzang@hallym.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Dae Young Zang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHA Bundang Medical centre</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chan Kim</last_name>
      <email>chan@cha.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Chan Kim</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joong Bae Ahn</last_name>
    </contact>
    <investigator>
      <last_name>Joong Bae Ahn</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ajou University Hospital</name>
      <address>
        <city>Suwon-si</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Seok Yun Kang</last_name>
      <email>Kangsy01@ajou.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Seok Yun Kang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penang Adventist Hospital</name>
      <address>
        <city>George Town</city>
        <state>Penang</state>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Sarawak General Hospital</name>
      <address>
        <city>Kuching</city>
        <state>Sarawak</state>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Hospital Kuala Lumpur</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>50586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ros Suzanna</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Malaysia Medical Center</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>59100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gwo Fang Ho</last_name>
    </contact>
    <investigator>
      <last_name>Gwo Fang Ho</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mastura Yusof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Kebangsaan Malaysia Medical Center</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Christchurch Public Hospital</name>
      <address>
        <city>Christchurch</city>
        <zip>8140</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Jeffrey</last_name>
      <email>Mark.jeffery@cdhb.health.nz</email>
    </contact>
    <investigator>
      <last_name>Mark Jeffrey</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dunedin Hospital</name>
      <address>
        <city>Dunedin</city>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Jackson</last_name>
      <email>Christopher.Jackson@southerndhb.govt.nz</email>
    </contact>
    <investigator>
      <last_name>Christopher Jackson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Philippines General Hospital</name>
      <address>
        <city>Ermita</city>
        <state>Manilla</state>
        <country>Philippines</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>King Fahad Medical City</name>
      <address>
        <city>Riyadh</city>
        <zip>11525</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Abdullah Al Sharm</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Cancer Centre - Singapore</name>
      <address>
        <city>Singapore</city>
        <zip>169610</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chee Kian Tham</last_name>
      <email>tham.c.k@nccs.com.sg</email>
    </contact>
    <investigator>
      <last_name>Chee Kian Tham</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Iain Tan</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Su Pin Choo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Singapore International Medical Center</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>Tan Tock Seng Hospital</name>
      <address>
        <city>Singapore</city>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>National Cancer Institute</name>
      <address>
        <city>Maharagama</city>
        <country>Sri Lanka</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Asita de Silva</last_name>
      <email>asita@sltnet.lk</email>
    </contact>
    <investigator>
      <last_name>Mahendra Perera</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shuang Ho Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>23561</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Tsu Yi Chao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Koo Foundation Sun Yat Sen Cancer Centre</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>I-Ping Huang</last_name>
      <email>iphuang@kfsyscc.org</email>
    </contact>
    <investigator>
      <last_name>I-Ping Huang</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hung Chen Cheng</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Taipei Medical University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Po Li Wei</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wan Fang Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gi Ming Lai</last_name>
      <email>gminlai@nhri.org.tw</email>
    </contact>
    <investigator>
      <last_name>Gi Ming Lai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>China</country>
    <country>India</country>
    <country>Indonesia</country>
    <country>Korea, Republic of</country>
    <country>Malaysia</country>
    <country>New Zealand</country>
    <country>Philippines</country>
    <country>Saudi Arabia</country>
    <country>Singapore</country>
    <country>Sri Lanka</country>
    <country>Taiwan</country>
  </location_countries>
  <removed_countries>
    <country>Thailand</country>
  </removed_countries>
  <link>
    <url>https://www.ascolt.org</url>
    <description>Trial Website</description>
  </link>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2007</study_first_submitted>
  <study_first_submitted_qc>November 29, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2007</study_first_posted>
  <last_update_submitted>December 29, 2017</last_update_submitted>
  <last_update_submitted_qc>December 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Centre, Singapore</investigator_affiliation>
    <investigator_full_name>John Chia Whay Kuang</investigator_full_name>
    <investigator_title>Senior Consultant</investigator_title>
  </responsible_party>
  <keyword>stage II colon cancer</keyword>
  <keyword>stage III colon cancer</keyword>
  <keyword>stage II rectal cancer</keyword>
  <keyword>stage III rectal cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

